Richard Rosenquist Brandell, Genomic Medicine Sweden, Sweden

Richard Rosenquist Brandell, MD, PhD, is Professor of Clinical Genetics at Karolinska Institutet, and Senior Physician at Karolinska University Hospital, Stockholm, Sweden. He is also Director of Genomic Medicine Sweden, a national infrastructure for implementing precision medicine. By utilizing cutting‐edge molecular tools, Richard Rosenquist Brandell and his team have made outstanding contributions to our understanding of the onset and evolution of chronic lymphocytic leukemia (CLL), the most common leukemia. In addition to deciphering the molecular landscape of CLL by integrated multi-omics analysis and providing compelling evidence of antigen involvement in CLL pathogenesis, they have discovered novel prognostic/predictive biomarkers and drug targets, defined new clinically relevant subgroups, and designed improved risk-stratification models, hence paving the way for implementing precision medicine in CLL. Richard Rosenquist Brandell is a member of the Nobel Assembly at Karolinska Institutet.

Read more